HUTCHMED (China) (HMDCF) Assets Average (2016 - 2026)
HUTCHMED (China)'s (HMDCF) quarterly Assets Average came in at $1.7 billion in Q2 2026, down 1.12% quarter-over-quarter from $1.8 billion in Q4 2025.
Analysis
HUTCHMED (China) (HMDCF) Assets Average (2016 - 2026) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Assets Average for 9 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average changed N/A year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $1.7 billion, a N/A change from a year earlier, with the FY2022 full-year figure at $1.2 billion, up 14.56% from the prior year.
- Assets Average was $1.7 billion for Q2 2026 at HUTCHMED (China), down from $1.8 billion in the prior quarter.
- Over five years, Assets Average peaked at $1.8 billion in Q4 2025 and troughed at $1.1 billion in Q4 2022.
- A 4-year average of $1.4 billion and a median of $1.3 billion in 2022 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 30.57% in 2022 and slipped 9.35% in 2023, its largest moves.
- Over 4 years, Assets Average stood at $1.1 billion in 2022, then grew by 4.64% to $1.2 billion in 2023, then jumped by 51.66% to $1.8 billion in 2025, then fell by 1.12% to $1.7 billion in 2026.
- The last three Assets Average figures came in at $1.7 billion (Q2 2026), $1.8 billion (Q4 2025), and $1.2 billion (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 11.22 Bn |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | 5.51 Bn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | 1.74 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Bn |
| Dec 31, 2025 | 1.76 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Jun 30, 2022 | 1.28 Bn |
| Jun 30, 2021 | 983.00 Mn |
| Mar 31, 2021 | 708.62 Mn |
| Dec 31, 2020 | 624.84 Mn |
| Dec 31, 2019 | 459.61 Mn |
| Sep 30, 2019 | 474.65 Mn |
| Jun 30, 2019 | 517.26 Mn |
| Mar 31, 2019 | 535.71 Mn |
| Dec 31, 2017 | 471.32 Mn |
| Jun 30, 2017 | 343.57 Mn |
| Dec 31, 2016 | 332.64 Mn |
| Jun 30, 2016 | 276.22 Mn |